|
Annals of African Medicine
Annals of African Medicine Society
ISSN: 1596-3519
Vol. 5, Num. 4, 2006, pp. 185-187
|
Hepatitis C virus (HCV) infection among hospital patients in Kano
Annals of African Medicine, Vol. 5, No. 4, 2006, pp. 185-187
Hepatitis
C Virus Infection among Teaching Hospital Patients in Kano, Nigeria: A Retrospective Study
1 E. E. Nwokedi, 2Z. Ilyasu, 3M.
A. Emokpae, 4A. I. Dutse and 5A. A. Taura
1Departments of Medical Microbiology and Parasitology, 2Community
Medicine, 3Chemical Pathology, 4Medicine and 5Psychiatry,
Bayero University, Kano, Nigeria
Reprint requests to: Dr. E.E Nwokedi, Department of Medical
Microbiology and Parasitology, Aminu Kano Teaching Hospital, P. M. B. 3452,
Kano, Nigeria
Code Number: am06044
Abstract
Background:Chronic infection with hepatitis C is considered to be a causative
factor in hepatocellular carcinoma. The prevalence of this virus in Kano is not known.
Method:A total of one thousand and seven subjects were recruited for the
study. They included 681 males and 326 females. Hepatitis C virus (HCV)
antibody was tested using ELISA technique with reagent supplied by Anhet
laboratory, Cortex, USA.
Results:A total of sixty two subjects were positive out of one thousand and
seven, with a period prevalence rate of 6.2% and confidence interval of 5.4
6.9%.
Conclusion: Even though Nigeria does not lye within HCV endemic region, this study shows that the prevalence rate
of 6.2% is quite significant. It is suggested that HCV antibody screening
should be included in the screening tests carried out in blood banks and in
patients with sexually transmitted diseases.
Key words: Hepatitis, HCV, hepatocellular carcinoma
Résumé
Introduction: Infection chronique avec hépatite C est considerée dêtre un facteur causatif
dans carcinome hépatocellulaire. La fréquence de ce virus à Kano nest pas
connu.
Méthode: Un total
de mille et sept sujets ont été récrutés pour cette étude, y compris 681 du
sexe masculin, 326 du sexe féminin. On avait fait lexamen danticorps virus C
hépatite à travers lutilisation de la technique dELISA avec le réactif fourni
par laboratoire de Anhet, Cortex, USA.
Résultats : Un total de soixante deux sujets étaient positif entre mille et sept, avec un
taux de la période de la fréquence de 6,2% et interval de la confiance de 5,4
6,9%.
Conclusion:
Quoique le Nigéria nentre pas dans la région endémique du VCH, cette étude
montre que le taux de la fréquence de 6,2% est assez importante. Nous
suggérons que le dépistage danticoprs du VCH devrait être inclu dans lexamen
de dépistage effectué dans la bangue du sang et chez des patientes avec des
maladies sexuellement transmissible.
Mot-clés: Hépatite, VCH, carcinome hépatocellulaire
Introduction
Hepatitis C, a member of the
Flaviviridae family, contains a genome of single stranded RNA 9.4kb in size. It
appears that the majority of infections become persistent, even in adults. Chronic
infection with hepatitis C virus (HCV) is also considered to be a causative
factor in hepatocellular carcinoma.1 Most probably, HCV acts
indirectly in the development of hepatocellular carcinoma (HCC). There are
currently over 250 million people worldwide persistently infected with
hepatitis B virus and over 170million chronic carriers of hepatitis C virus
large pool of individuals at risk of developing liver cancer.1-2
In
approximately 50% of individuals diagnosed with sporadic hepatitis C, the
source of infection is unknown2. Hepatitis C is particularly
prevalent in some developing countries. The incidence varies from 0.05% to 3%
in various countries. There is a high prevalence in Japan, the Mediterranean
countries of Europe and the Middle East. Reported prevalence rates in Africa vary between 0.41% and 12%.3 HCV is transmitted primarily through
blood and blood products. Other routes of HCV transmission include sexual, vertical,
tissue/organ transplantation and via house hold contacts. 3 In most cases infection is associated with high risk life-style or particular
demographic groups rather than a specific route of transmission. Recent reports
suggest that the prevalence of hepatitis C infection in normal Africans may be
as high as 10.9% while the corresponding value for patients with primary liver
cell carcinoma (PLCC) would be about 18.7 38%. 4 The prevalence
of HCV in Kano, Nigeria is not known.
Subjects and
Methods
One thousand and seven
consecutive subjects referred to the laboratory from the various clinics and
wards of Aminu Kano Teaching Hospital, Kano, Nigeria for HCV antibody screening
were included in the study between January 2002 and December 2003. They were
681 males and 326 females. They include patients suspected of HCV infection.
Blood donors and HIV positive patients were excluded from this study.
Blood
samples were collected aseptically in to plain bottles which were allowed to
clot for 20 minutes at room temperature. The samples were centrifuged to obtain
sera at 1000g for 10 minutes. HCV antibody testing was done using ELISA
technique (HCV Murex 40, Anhet laboratories, USA). Manufacturers
instructions were strictly adhered to and control sera were included at every
run. Chi square statistical analysis was used to compare the results.
Results
Out of 1007 patients tested
over the two year period, 62 were hepatitis C antibody positive giving a period
seroprevalence rate of 6.2% with a 95% confidence interval of 5.4% to
6.9%.Table 1 shows the distribution of HCV infection according to gender. Out
of the 681 males tested 38 (5.6%) were seropositive for hepatitis C antibody.
Similarly out of the 326 females tested, 24 (7.4%) were seropositive.
The
difference was not statistically significant (X2 @ 1df and p >
0.05=0.27) although a higher proportion of females (7.4%) were seropositive
compared to males (5.6%).
Table
2 shows the distribution of HCV infection rate according to age groups. The
results show that the lowest prevalence rate was 1.6% in the first ten years of
life while the highest was 10.1% among those in age bracket 31-40years. In the
first and second decades, the total numbers tested were the lowest which was 62
and 78 respectively. There were over a hundred and thirty sera in the other age
groups.
Table 1: Hepatitis C seropositivity
and sex in 1007 subjects
Sex |
No. seropositive (%) |
No. seronegative (%) |
Total |
Males |
38(5.6) |
643(94.4) |
681 |
Females |
24(7.4) |
302(92.6) |
326 |
Total (%) |
62(6.2) |
945(93.8) |
1007(100) |
p = 0.27 (not significant)
Table 2: Hepatitis C virus
positivity and age in 1007 subjects
Age (years) |
No. seropositive (%) |
No. seronegative (%) |
Total |
≤10 |
1(1.6) |
61(98.4) |
60 |
11 20 |
6(7.7) |
72(92.3) |
78 |
21 30 |
8(4.8) |
157(95.2) |
165 |
31 40 |
20(10.1) |
179(89.9) |
199 |
41 50 |
9(6.5) |
129(93.5) |
138 |
>50 |
11(6.1) |
168(93.9) |
179 |
Not stated |
7(3.8) |
179(96.2) |
186 |
Total (%) |
62(6.2) |
945(93.8) |
1007(100) |
Discussion
Antibody to hepatitis C was
found in 6.2% of the subjects screened for HCV infection at Aminu Kano Teaching
Hospital, Kano between January 2002 and December 2003. This is comparable to
the recent estimates in West African countries that range from 1.1% to 6.7%, 5 7% of a cohort of 58 people living with Aids receiving HART in Dakar, Senegal,
5% among sickle cell anaemia patients of Lagos University Teaching Hospital and
6% among patients with a previous history of traditional surgery6.
However, our result is less than 14% found at University of Benin Teaching
Hospital among accident and emergency patients by Halim et al, 7 18.7% found among patients with hepatocellular carcinoma at Ibadan by Olubuyide
et al, 8 24% found among patients with acute icteric hepatitis also
at Ibadan, 9 and
19.4% found among sickle cell disease patients attending a haematology clinic
in Ibadan, Nigeria. 10 This 6.2% prevalence rate in Kano patients is
however higher than 1.6% found in Dakar, Senegal among blood donors, 5 Mauritania 1.1% and Benin 1.4% respectively. 5
Gender-wise,
we found that 5.6% of males and 7.4% of females respectively are seropositive
to hepatitis C antibodies in Kano. Although a higher proportion of females
(7.4%) were seropositive compared to males (5.6%), this difference was not
statistically significant. Among different age-groups however, 31-40 age-groups
has the highest compared to age group below 10 years. This age group is among
those associated with the likelihood of heterosexual transmission of hepatitis
C, intravenous drug use and other high risks related to acquisition of
hepatitis C.7
This study shows that HCV infection is prevalence
among patients in Kano, Nigeria. These individuals with hepatitis C antibody can
infect their sexual partners if they donate blood to any family member who
needs blood the recipient may be infected. Any infected person may develop
severe liver disease such as liver cirrhosis and or hepatocellular carcinoma.
This should be a source of concern to both health care providers and policy
makers.
Hepatitis
C antibody screening should be included as one of the diseases screened for
among blood donors, intravenous drug users, sexually transmitted infection clients
and others with high risk behaviour. A larger survey needs to be carried out
among the general population of Kano as well as among the high risk groups.
This will enable the government determine the true level of infection in the
population and how best to tackle it.
References
-
Jawetz CW. Medical microbiology. Lange, Connecticut, 2001; 403 409
-
Shenson DC. Microbiology
in clinical practice. Butterworth Heinemann, 2000; 277-294
-
Ayodele OE, Salako BL. Hepatitis C
virus and chronic renal disease. Afr J Med med Sci 2003;32: 287-291
-
Bojuwole BJ. The burden of viral
hepatitis in Africa. West Afr J Med 1997; 16:198-203
-
Etard J-F, Colbachini P, Dromigny J-A,
et al. Emerg Infect Dis 2003; l9;1492-1493
-
Lesi OA, Kehinde MO. Hepatitis C
virus infection in patients with sickle cell anemia at the Lagos University Hospital. Niger Postgrad Med J 2003;10:79-83
-
Halim NK, Madukwe U, Saheeb BD, et
al, Hepatitis B surface antigen and antibody to hepatitis C virus among
accident and emergency patients. East Afr Med J 2001; 78: 480-483
-
Olubuyide IO, Aliyu B, Olaleye OA,
et al. Hepatitis B and C viruses and hepatocellular carcinoma. Trans R Soc Trop
Med Hyg 1997; 91: 38-41
-
Ola SO, Otegbayo JA, Odaibo GN, et
al. Serum hepatitis C virus and hepatitis B surface antigenaemia in Nigerian
patients with acute icteric hepatitis. West Afr J Med 2002; 21:215-217
-
Fasola FA, Odaibo GN, Alenova YA,
et al. Hepatitis B and C viral markers in patients with sickle cell disease in
Ibadan, Nigeria. Afr J Med med Sci 2003; 32: 293-295
Copyright 2006 - Annals of African Medicine
|